Skip to main content

Table 4 Relevance of concerns about regulations of HRMDs and procurement processes, and about factors influencing procurement

From: Effects of procurement practices on quality of medical device or service received: a qualitative study comparing countries

Stakeholder group

Mexico

Switzerland

Germany

UK

Total

Regulations for market approval

 Group 1

-

+++

+++

+++

++(+)

 Group 2

-

++

++

+++

+(+)

 Group 3

++

+++

+++

+++

++(+)

 Group 4

++

+++

+++

+++

++(+)

Total

+

++(+)

++(+)

+++

 

Regulations for eligibility

 Group 1

+

++

+++

+++

++(+)

 Group 2

-

+++

++

++

+(+)

 Group 3

++

+++

+++

+++

++(+)

 Group 4

++

++

+++

+++

++

Total

+

++

++(+)

++(+)

 

Procurement regulations and practices

 Group 1

++

-

-

-

(+)

 Group 2

-

-

-

-

-

 Group 3

+++

-

+

-

+

 Group 4

+++

-

+

-

+

Total

++

-

(+)

-

 

Programmes targeting quality and supporting procurement

 Group 1

+

-

-

-

(+)

 Group 2

+

-

-

-

(+)

 Group 3

++

-

-

-

(+)

 Group 4

++

-

-

-

(+)

Total

+(+)

-

-

-

 

Factors influencing procurement

 Cost

+++

-

+

-

+

 Knowledge

+++

-

+

-

+

 Clinical evidence

+++

-

-

-

+

 Procurement setting

+++

-

-

-

+

Total

+++

-

(+)

-

 
  1. +++ very relevant ++ moderate relevant + relevant - not relevant